Top 9 best understanding pharma
Finding the best understanding pharma suitable for your needs isnt easy. With hundreds of choices can distract you. Knowing whats bad and whats good can be something of a minefield. In this article, weve done the hard work for you.
1. Understanding Pharma: The Professional's Guide To How Pharmaceutical And Biotech Companies Really Work
Feature
Used Book in Good ConditionDescription
The pharmaceutical industry is extremely complex, and so are the inner workings of the pharmaceutical and biotechnology companies operating within it. Even the most seasoned industry professionals may find it difficult to understand the activities of, and interdependencies among, all key functions within a pharmaceutical or biotechnology company. Yet this knowledge is crucial when the responsibilities for--or repercussions of--key initiatives ripple across an organization.Understanding Pharma is a must-read for anyone in the pharma/biotech sector--those new to the industry, industry veterans, and specialized experts working in or serving the industry.
The Understanding Pharma book and 10-module e-course series have been incorporated into the on-boarding and professional development programs of numerous leading pharmaceutical and biotech companies, as well as university curricula for students preparing for careers in the industry. Two full printings of the first edition--more than 5,000 books--have sold out.
This third edition provides key updates to content, including a new Medical Affairs chapter and new content related to the distinctive issues and requirements surrounding biopharmaceuticals. There are also major updates to the Managed Markets and Trade and Distribution chapters. Key data points have been revised throughout the book to maintain currency.
Topics covered in the book include:
Each function-specific chapter explains:
Understanding Pharma is an ideal resource for professionals in a wide variety of careers, including:
Students preparing for careers in the pharmaceutical industry will also find it extremely effective in orienting them to their chosen field, and the industry as a whole.
Be sure your team has what it takes to succeed in this competitive environment. Understanding Pharma will provide the practical knowledge they need. Also be sure to check out the companion book, Lingua Pharma, the first comprehensive glossary of industry-related terms.Understanding Pharma is an introduction to how pharmaceutical and biotechnology companies actually work, from both a scientific and a business standpoint.
2. Understanding Pharma: A Primer on How Pharmaceutical Companies Really Work
Feature
Used Book in Good ConditionDescription
The pharmaceutical industry is extremely complex, and so are the inner workings of the pharmaceutical and biotechnology companies operating within it. Even the most seasoned industry professionals may find it difficult to understand the activities of, and interdependencies among, all key functions within a pharmaceutical company. Yet this knowledge is crucial when the responsibilities for--or repercussions of--key initiatives ripple across an organization.Understanding Pharma is a must-read for anyone in the pharmaceutical industry--those new to the industry, industry veterans, and those working in or serving the industry.
Topics covered in the book include:
Each function-specific chapter explains:
Understanding Pharma is an ideal resource for professionals in a wide variety of careers, including:
Students preparing for careers in the pharmaceutical industry will also find it extremely effective in orienting them to their chosen field, and the industry as a whole.
Be sure your team has what it takes to succeed in this competitive environment. Understanding Pharma will provide the practical knowledge they need. Also be sure to check out the companion book, Lingua Pharma, the first comprehensive glossary of industry-related terms.
3. Business Development for the Biotechnology and Pharmaceutical Industry
Description
Business Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects. The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.4. Modern Pharmaceutical Industry: A Primer
Feature
Used Book in Good ConditionDescription
Modern Pharmaceutical Industry: A Primer comprehensively explains the broad range of divisions in the complex pharmaceutical industry. Experts actively involved in each component discuss their own contribution to a pharmaceutical company's work and success. Divisions include regulatory affairs, research and development, intellectual property, pricing, marketing, generics, OTC, and more. The seventeen chapters included in this resource offer a wide range of topics, from discovery and formulation to post-approval and legal. Readers will be given a detailed look at the structure of a contemporary drug company and a thorough understanding of what goes on behind the scenes.Modern Pharmaceutical Industry: A Primer is a valuable resource for all pharmacy students, new hires at pharmaceutical companies, drug company management, and academic health center libraries. No other text provides a comprehensive look at one of the most dynamic industries related to the modern healthcare system.
5. Lingua Pharma: A Glossary of Terms for the Pharmaceutical Industry
Feature
Used Book in Good ConditionDescription
Lingua Pharma is a glossary of common terms and abbreviations used in the pharmaceutical and biotech industries. It is a valuable reference tool that provides practical definitions that readers can readily understand and put to work. It is a perfect companion to the Pharmaceutical Institute's Understanding Pharma book--the first, practical guide to how pharmaceutical and biotech companies really work.6. Understanding Pharma: A Primer on How Pharmaceutical Companies Really Work by John J. Campbell (2005-08-01)
7. CFA Institute Industry Guides: The Pharmaceutical Industry
Description
Among the most distinctive features of the pharmaceutical industry are the complexity and length of the product development cycle and the independence of a pharmaceutical companys operating performance from overall industry trends. The earnings outlook of an individual company is determined, first and foremost, by the products it develops and markets. Consequently, the industry is characterized by exceptional heterogeneity, which notably complicates peer group analyses and often entails divergent share price performance. Top-down analytical approaches based on overall market growth rates and market share development, often a good starting point in other industries, add limited value at best and may often be misleading. The quality of bottom-up analyses that take into account the clinical utility, cost-effectiveness, competitive landscape, intellectual property, and economics of individual drugs is typically the main success factor in selecting pharmaceutical and biotechnology stocks. In this comprehensive examination of the industry, the author delineates the determinants of success in drug development and marketing and then reviews portfolio considerations and the implications for financial statement analysis, forecasting, and valuation.8. Starting out in the pharma industry: Essential knowledge for life scientists (Life After Life Science) (Volume 1)
Description
Bored of academia? Sick of publish-or-perish and the grant-chasing treadmill? Youve probably thought about building a career in the pharmaceutical industry, only to find a confusing world of unfamiliar terminology, requirements, and job descriptions. This book explains the many complexities of the pharmaceutical industry: the processes, the expectations, the skills you need to know and the careers you can enter all laid out in an informative and jargon-free manner. For those who have started or want to start in the pharmaceutical industry, this book is a vital resource. What does it include? - An introduction to the entire drug development and manufacturing process. We examine how a drug goes from chemical entity to a final pharmaceutical; how drug batches are made, checked, and released to the market; we look at the marketing process, pharmacovigilance, and how processes change over time. - Industry expectations. We look at the knowledge you should learn during the first few weeks and months, attributes you should be cultivating, and how to work effectively with your manager. - Industry skills you need to succeed. We cover skills such as effective communication in all its forms, how to attend and run a meeting; how to organise information, how to cope with the sudden demands on your time and how to plan and execute projects succesfully. - Starting and building your pharmaceutical career. We describe the most common entry roles taken by life scientists entering industry and how you can develop your career beyond that initial step. - Finally our terminology list helps explain the multitude of pharmaceutical terms which you will come across in your career.9. The Truth About the Drug Companies: How They Deceive Us and What to Do About It
Feature
Random House TradeDescription
During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has becomeand argues for essential, long-overdue change.Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers.
Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective.
The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.
Recent Comments